Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2.
Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Natsuaki M, et al. Among authors: eizawa h. Circ Cardiovasc Interv. 2014 Apr;7(2):168-79. doi: 10.1161/CIRCINTERVENTIONS.113.000987. Epub 2014 Feb 18. Circ Cardiovasc Interv. 2014. PMID: 24550439
Stabilizing factor(s) of nitric oxide (NO) synthetase.
Kosuga K, Yui Y, Hattori R, Eizawa H, Hiki K, Kawai C. Kosuga K, et al. Among authors: eizawa h. Biochem Biophys Res Commun. 1990 Oct 30;172(2):705-8. doi: 10.1016/0006-291x(90)90731-2. Biochem Biophys Res Commun. 1990. PMID: 1700708
Three regulation mechanisms of nitric oxide synthase.
Hiki K, Yui Y, Hattori R, Eizawa H, Kosuga K, Kawai C. Hiki K, et al. Among authors: eizawa h. Eur J Pharmacol. 1991 Feb 25;206(2):163-4. doi: 10.1016/0922-4106(91)90026-e. Eur J Pharmacol. 1991. PMID: 1712309 No abstract available.
Cytosolic and membrane-bound nitric oxide synthase.
Hiki K, Yui Y, Hattori R, Eizawa H, Kosuga K, Kawai C. Hiki K, et al. Among authors: eizawa h. Jpn J Pharmacol. 1991 Jun;56(2):217-20. doi: 10.1254/jjp.56.217. Jpn J Pharmacol. 1991. PMID: 1715413 Free article.
Preferential inhibition of inducible nitric oxide synthase by ebselen.
Hattori R, Inoue R, Sase K, Eizawa H, Kosuga K, Aoyama T, Masayasu H, Kawai C, Sasayama S, Yui Y. Hattori R, et al. Among authors: eizawa h. Eur J Pharmacol. 1994 Apr 15;267(2):R1-2. doi: 10.1016/0922-4106(94)90179-1. Eur J Pharmacol. 1994. PMID: 7519560
Structure and function of nitric oxide synthases.
Hattori R, Sase K, Eizawa H, Kosuga K, Aoyama T, Inoue R, Sasayama S, Kawai C, Yui Y, Miyahara K, et al. Hattori R, et al. Among authors: eizawa h. Int J Cardiol. 1994 Dec;47(1 Suppl):S71-5. doi: 10.1016/0167-5273(94)90329-8. Int J Cardiol. 1994. PMID: 7537723 Review.
Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease: perspectives from the CREDO-Kyoto registry.
Furukawa Y, Taniguchi R, Ehara N, Ozasa N, Haruna Y, Saito N, Doi T, Hoshino K, Shizuta S, Morimoto T, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators. Furukawa Y, et al. Circ J. 2008 Dec;72(12):1937-45. doi: 10.1253/circj.cj-08-0293. Epub 2008 Oct 24. Circ J. 2008. PMID: 18948669 Free article.
50 results